| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 97.722 | 144.521 | 77.182 | 55.450 | 98.276 | 78.233 | 84.130 | 95.649 | 103.190 | 90.123 |
| Total Income - EUR | 97.726 | 144.613 | 77.326 | 56.097 | 99.767 | 80.477 | 85.560 | 97.317 | 104.849 | 92.754 |
| Total Expenses - EUR | 91.025 | 138.688 | 77.201 | 54.464 | 90.848 | 87.661 | 75.292 | 89.959 | 93.182 | 90.888 |
| Gross Profit/Loss - EUR | 6.701 | 5.925 | 125 | 1.634 | 8.919 | -7.184 | 10.268 | 7.358 | 11.667 | 1.866 |
| Net Profit/Loss - EUR | 6.701 | 4.927 | -775 | 1.073 | 7.922 | -7.933 | 9.431 | 6.534 | 10.737 | 439 |
| Employees | 9 | 9 | 5 | 4 | 5 | 5 | 4 | 4 | 4 | 3 |
Check the financial reports for the company - Biohelix Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.115 | 13.052 | 12.213 | 32.385 | 26.017 | 21.886 | 15.998 | 31.368 | 25.922 | 10.474 |
| Current Assets | 82.537 | 30.405 | 17.571 | 22.875 | 33.370 | 24.674 | 36.665 | 38.815 | 45.297 | 45.294 |
| Inventories | 17.843 | 4.874 | 3.973 | 2.836 | 2.084 | 1.863 | 1.195 | 18 | 18 | 17 |
| Receivables | 13.652 | 15.852 | 7.114 | 15.734 | 15.589 | 14.574 | 25.409 | 26.275 | 23.821 | 20.135 |
| Cash | 51.042 | 9.680 | 6.483 | 4.305 | 15.697 | 8.236 | 10.061 | 12.523 | 21.459 | 25.141 |
| Shareholders Funds | 86.588 | 33.907 | 26.336 | 26.925 | 34.325 | 25.741 | 34.602 | 41.243 | 48.217 | 38.406 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.065 | 9.550 | 3.448 | 28.334 | 25.062 | 20.818 | 18.062 | 28.939 | 23.002 | 17.363 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Biohelix Srl